Adjunct Episcleral Brachytherapy for PCV

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

159

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions

Age-Related Macular DegenerationPolypoid Choroidal Vasculopathy

Interventions

RADIATION

Episcleral Brachytherapy

Minimally invasive, single fraction brachytherapy

DRUG

Aflibercept Injection

Standard of Care intravitreal aflibercept injection

All Listed Sponsors

lead

Salutaris Medical Devices, Inc.

INDUSTRY